While hormone replacement therapy (HRT) is not broadly linked to young-onset breast cancer, using certain types before menopause could increase the risk of it developing in young women, a new study ...

There has been no lack of discussion over the years about the link between menopause and breast cancer—particularly whether menopause and its treatment options are breast cancer risk factors. And ...

Hormone replacement therapy (HRT) does not increase breast cancer risk in BRCA1/BRCA2 carriers, with estrogen-alone formulations showing a lower risk. The study used a matched-pair design to control ...

Women treated for breast cancer who are considering taking Hormone Replacement Therapy (HRT) should be cautious when using published research to inform their decision. An article published today in ...

For decades, breast cancer survivors going through menopause have been told that hormone therapy is off-limits—full stop. But new analyses and a 2025 expert consensus paper suggest that there may be ...

HRT does not increase breast cancer risk in BRCA1/BRCA2 variant carriers, with lower incidence in users versus non-users. Estrogen-alone therapy is linked to reduced mortality, while estrogen plus ...

Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results of a matched ...

The risk of breast cancer from hormonal replacement therapy (HRT) for the menopause is double what women are currently being told, according to a major piece of research. However, Breast cancer ...

Many people who’ve had breast cancer take medications – tamoxifen or aromatase inhibitors – to help prevent the cancer from coming back. Doctors prescribe them for people with “hormone positive” ...